Recall Enforment Report D-0856-2021

Drug Recall Enforcement Report Class II voluntary initiated by Fresenius Kabi USA LLC, originally initiated on 09-17-2021 for the product Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper The product was recalled due to defective container: cracked vials leading to lack of sterility assurance. The product was distributed nationwide and the recall is currently ongoing.

Field Name Field Value
Event ID 88698 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-0856-2021 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern U.S.A. Nationwide What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01. 25 vials per tray packaged 18 trays per shipper
Reason For Recall Defective container: Cracked vials leading to lack of sterility assurance What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 963000 vials Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 10-06-2021
Recall Initiation Date 09-17-2021 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Fresenius Kabi USA LLC
Code Info Lot # 6023731, 6023732, Exp 03/2023; 6024172, 6024260, Exp 06/2023 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 63323-452-00; 63323-452-01; 63323-454-00; 63323-454-01; 63323-455-00; 63323-455-01; 63323-458-00; 63323-458-01; 63323-451-00; 63323-451-01
Status Ongoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
63323-451Morphine Sulfate Morphine SulfateInjection, SolutionIntramuscular; IntravenousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-452Morphine Sulfate Morphine SulfateInjection, SolutionIntramuscular; IntravenousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-454Morphine Sulfate Morphine SulfateInjection, SolutionIntramuscular; IntravenousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-455Morphine Sulfate Morphine SulfateInjection, SolutionIntramuscular; IntravenousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-458Morphine Sulfate Morphine SulfateInjection, SolutionIntramuscular; IntravenousFresenius Kabi Usa, LlcHuman Prescription Drug